Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

November 01, 2004; Volume 32,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adelsberger, Jennifer K.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  2. Afzelius, Lovisa

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218
  3. Allers, Paul

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304
  4. Andersson, Tommy B.

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218

B

  1. Baillie, Thomas A.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  2. Baker, Maribeth P.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  3. Bakhtiar, Ray

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
  4. Ball, Simon E.

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  5. Benet, Leslie Z.

    1. You have access
      EFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN
      Hong Sun, Yong Huang, Lynda Frassetto and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1239-1246; DOI: https://doi.org/10.1124/dmd.104.000521
    2. You have access
      HEPATIC MICROSOME STUDIES ARE INSUFFICIENT TO CHARACTERIZE IN VIVO HEPATIC METABOLIC CLEARANCE AND METABOLIC DRUG-DRUG INTERACTIONS: STUDIES OF DIGOXIN METABOLISM IN PRIMARY RAT HEPATOCYTES VERSUS MICROSOMES
      Justine L. Lam and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1311-1316; DOI: https://doi.org/10.1124/dmd.32.11.1311
  6. Beno, David W. A.

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  7. Booth-Genthe, Catherine L.

    1. You have access
      HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION
      Donghui Cui, Catherine L. Booth-Genthe, Edward Carlini, Brian Carr and Michael L. Schrag
      Drug Metabolism and Disposition November 2004, 32 (11) 1260-1264; DOI: https://doi.org/10.1124/dmd.32.11.1260
  8. Brunner, Janice E.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422

C

  1. Carlini, Edward

    1. You have access
      HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION
      Donghui Cui, Catherine L. Booth-Genthe, Edward Carlini, Brian Carr and Michael L. Schrag
      Drug Metabolism and Disposition November 2004, 32 (11) 1260-1264; DOI: https://doi.org/10.1124/dmd.32.11.1260
  2. Carr, Brian

    1. You have access
      HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION
      Donghui Cui, Catherine L. Booth-Genthe, Edward Carlini, Brian Carr and Michael L. Schrag
      Drug Metabolism and Disposition November 2004, 32 (11) 1260-1264; DOI: https://doi.org/10.1124/dmd.32.11.1260
  3. Chen, Yong

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  4. Cherrington, Nathan J.

    1. You have access
      DOWN-REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDE 4 (Oatp4; Oatp1b2; Slc21a10) mRNA BY LIPOPOLYSACCHARIDE THROUGH THE TOLL-LIKE RECEPTOR 4 (TLR4)
      Ning Li, Supratim Choudhuri, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2004, 32 (11) 1265-1271; DOI: https://doi.org/10.1124/dmd.32.11.1265
  5. Chichester, Clinton O.

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  6. Chiu, Shuet-Hing Lee

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
  7. Choudhuri, Supratim

    1. You have access
      DOWN-REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDE 4 (Oatp4; Oatp1b2; Slc21a10) mRNA BY LIPOPOLYSACCHARIDE THROUGH THE TOLL-LIKE RECEPTOR 4 (TLR4)
      Ning Li, Supratim Choudhuri, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2004, 32 (11) 1265-1271; DOI: https://doi.org/10.1124/dmd.32.11.1265
  8. Cui, Donghui

    1. You have access
      HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION
      Donghui Cui, Catherine L. Booth-Genthe, Edward Carlini, Brian Carr and Michael L. Schrag
      Drug Metabolism and Disposition November 2004, 32 (11) 1260-1264; DOI: https://doi.org/10.1124/dmd.32.11.1260
    2. You have access
      SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
      Michael L. Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma and A. David Rodrigues
      Drug Metabolism and Disposition November 2004, 32 (11) 1299-1303; DOI: https://doi.org/10.1124/dmd.32.11.1299

D

  1. de Almeida, Isabel Tavares

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304
  2. Duran, Marinus

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304
  3. Dybdal, Noel

    1. You have access
      TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING NUDE MICE
      Hong Xiang, Cindy B. Nguyen, Sean K. Kelley, Noel Dybdal and Enrique Escandón
      Drug Metabolism and Disposition November 2004, 32 (11) 1230-1238; DOI: https://doi.org/10.1124/dmd.104.000323

E

  1. Ellis, S. W.

    1. You have access
      MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180
  2. Escandón, Enrique

    1. You have access
      TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING NUDE MICE
      Hong Xiang, Cindy B. Nguyen, Sean K. Kelley, Noel Dybdal and Enrique Escandón
      Drug Metabolism and Disposition November 2004, 32 (11) 1230-1238; DOI: https://doi.org/10.1124/dmd.104.000323
  3. Evans, David C.

    1. You have access
      THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
      Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
    2. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216

F

  1. Ford, Michael

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  2. Franklin, Ronald B.

    1. You have access
      THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
      Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
  3. Frassetto, Lynda

    1. You have access
      EFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN
      Hong Sun, Yong Huang, Lynda Frassetto and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1239-1246; DOI: https://doi.org/10.1124/dmd.104.000521

G

  1. Galinsky, Raymond E.

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  2. Giraud, Carole

    1. You have access
      IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
  3. Goosen, Theunis C.

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  4. Gross, Gerhard

    1. You have access
      HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497

H

  1. Hall, Stephen D.

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  2. Henderson, Paul T.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  3. Heydari, A.

    1. You have access
      MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180
  4. Huang, Yong

    1. You have access
      EFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN
      Hong Sun, Yong Huang, Lynda Frassetto and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1239-1246; DOI: https://doi.org/10.1124/dmd.104.000521
  5. Hurst, Susan

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  6. Huskey, Su-Er W.

    1. You have access
      THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
      Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
    2. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
  7. Hyland, Ruth

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794

I

  1. IJlst, Lodewijk

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304

J

  1. Jakobs, Cornelis

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304
  2. Jiyamapa-Serna, Vanida A.

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  3. Jones, Barry C.

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  4. Jørgensen, Flemming Steen

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218

K

  1. Karlén, Anders

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218
  2. Kelley, Sean K.

    1. You have access
      TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING NUDE MICE
      Hong Xiang, Cindy B. Nguyen, Sean K. Kelley, Noel Dybdal and Enrique Escandón
      Drug Metabolism and Disposition November 2004, 32 (11) 1230-1238; DOI: https://doi.org/10.1124/dmd.104.000323
  3. Khan, Ikhlas A.

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  4. Kimura, Robert E.

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  5. Klaassen, Curtis D.

    1. You have access
      DOWN-REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDE 4 (Oatp4; Oatp1b2; Slc21a10) mRNA BY LIPOPOLYSACCHARIDE THROUGH THE TOLL-LIKE RECEPTOR 4 (TLR4)
      Ning Li, Supratim Choudhuri, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2004, 32 (11) 1265-1271; DOI: https://doi.org/10.1124/dmd.32.11.1265
  6. Koup, Jeffrey R.

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  7. Kretz, Olivier

    1. You have access
      HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497
  8. Kunta, Jeevan R.

    1. You have access
      DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752

L

  1. Lam, Justine L.

    1. You have access
      HEPATIC MICROSOME STUDIES ARE INSUFFICIENT TO CHARACTERIZE IN VIVO HEPATIC METABOLIC CLEARANCE AND METABOLIC DRUG-DRUG INTERACTIONS: STUDIES OF DIGOXIN METABOLISM IN PRIMARY RAT HEPATOCYTES VERSUS MICROSOMES
      Justine L. Lam and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1311-1316; DOI: https://doi.org/10.1124/dmd.32.11.1311
  2. Lee, Sung-Hack

    1. You have access
      DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752
  3. Lee, Yong-Hee

    1. You have access
      DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752
  4. Lennard, M. S.

    1. You have access
      MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180
  5. Li, Ning

    1. You have access
      DOWN-REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDE 4 (Oatp4; Oatp1b2; Slc21a10) mRNA BY LIPOPOLYSACCHARIDE THROUGH THE TOLL-LIKE RECEPTOR 4 (TLR4)
      Ning Li, Supratim Choudhuri, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2004, 32 (11) 1265-1271; DOI: https://doi.org/10.1124/dmd.32.11.1265
  6. Liu, Jirong

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  7. Lu, Ping

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216

M

  1. Ma, Bennett

    1. You have access
      SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
      Michael L. Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma and A. David Rodrigues
      Drug Metabolism and Disposition November 2004, 32 (11) 1299-1303; DOI: https://doi.org/10.1124/dmd.32.11.1299
  2. Ma, Yuzhong

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  3. Masimirembwa, Collen M.

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218
  4. McGinnity, Dermot F.

    1. You have access
      EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE
      Dermot F. McGinnity, Matthew G. Soars, Richard A. Urbanowicz and Robert J. Riley
      Drug Metabolism and Disposition November 2004, 32 (11) 1247-1253; DOI: https://doi.org/10.1124/dmd.104.000026

N

  1. Newton, Deborah J.

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
  2. Nguyen, Cindy B.

    1. You have access
      TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING NUDE MICE
      Hong Xiang, Cindy B. Nguyen, Sean K. Kelley, Noel Dybdal and Enrique Escandón
      Drug Metabolism and Disposition November 2004, 32 (11) 1230-1238; DOI: https://doi.org/10.1124/dmd.104.000323

P

  1. Pearson, Paul G.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  2. Perry, Barbara A.

    1. You have access
      DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752
  3. Peterkin, Vincent

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  4. Pons, Gérard

    1. You have access
      IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279

R

  1. Raubacher, Florian

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218
  2. Rey, Elisabeth

    1. You have access
      IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
  3. Riley, Robert J.

    1. You have access
      EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE
      Dermot F. McGinnity, Matthew G. Soars, Richard A. Urbanowicz and Robert J. Riley
      Drug Metabolism and Disposition November 2004, 32 (11) 1247-1253; DOI: https://doi.org/10.1124/dmd.104.000026
  4. Rodrigues, A. David

    1. You have access
      SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
      Michael L. Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma and A. David Rodrigues
      Drug Metabolism and Disposition November 2004, 32 (11) 1299-1303; DOI: https://doi.org/10.1124/dmd.32.11.1299
  5. Rose, Mark J.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  6. Rostami-Hodjegan, A.

    1. You have access
      MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180
  7. Rushmore, Thomas H.

    1. You have access
      SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
      Michael L. Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma and A. David Rodrigues
      Drug Metabolism and Disposition November 2004, 32 (11) 1299-1303; DOI: https://doi.org/10.1124/dmd.32.11.1299

S

  1. Sachdeva, Karuna

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  2. Sanchez, Rosa I.

    1. You have access
      THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
      Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
    2. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
  3. Sandhu, Punam

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  4. Schrag, Michael L.

    1. You have access
      HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION
      Donghui Cui, Catherine L. Booth-Genthe, Edward Carlini, Brian Carr and Michael L. Schrag
      Drug Metabolism and Disposition November 2004, 32 (11) 1260-1264; DOI: https://doi.org/10.1124/dmd.32.11.1260
    2. You have access
      SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
      Michael L. Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma and A. David Rodrigues
      Drug Metabolism and Disposition November 2004, 32 (11) 1299-1303; DOI: https://doi.org/10.1124/dmd.32.11.1299
  5. Shou, Magang

    1. You have access
      SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
      Michael L. Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma and A. David Rodrigues
      Drug Metabolism and Disposition November 2004, 32 (11) 1299-1303; DOI: https://doi.org/10.1124/dmd.32.11.1299
  6. Silva, Margarida F. B.

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304
  7. Sinko, Patrick J.

    1. You have access
      DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752
  8. Smith, Dennis A.

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
  9. Soars, Matthew G.

    1. You have access
      EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE
      Dermot F. McGinnity, Matthew G. Soars, Richard A. Urbanowicz and Robert J. Riley
      Drug Metabolism and Disposition November 2004, 32 (11) 1247-1253; DOI: https://doi.org/10.1124/dmd.104.000026
  10. Sugiyama, Yuichi

    1. You have access
      HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497
  11. Sun, Hong

    1. You have access
      EFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN
      Hong Sun, Yong Huang, Lynda Frassetto and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1239-1246; DOI: https://doi.org/10.1124/dmd.104.000521

T

  1. Takada, Tappei

    1. You have access
      HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497
  2. Tran, Agnès

    1. You have access
      IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
  3. Tréluyer, Jean-Marc

    1. You have access
      IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
  4. Tucker, G. T.

    1. You have access
      MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180

U

  1. Ubick, Esther A.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  2. Uhing, Michael R.

    1. You have access
      THE EFFECT OF ANESTHESIA AND SURGERY ON CYP3A ACTIVITY IN RATS
      Michael R. Uhing, David W. A. Beno, Vanida A. Jiyamapa-Serna, Yong Chen, Raymond E. Galinsky, Stephen D. Hall and Robert E. Kimura
      Drug Metabolism and Disposition November 2004, 32 (11) 1325-1330; DOI: https://doi.org/10.1124/dmd.104.000927
  3. Urbanowicz, Richard A.

    1. You have access
      EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE
      Dermot F. McGinnity, Matthew G. Soars, Richard A. Urbanowicz and Robert J. Riley
      Drug Metabolism and Disposition November 2004, 32 (11) 1247-1253; DOI: https://doi.org/10.1124/dmd.104.000026

V

  1. Vincent, Jean

    1. You have access
      IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
      Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
      Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
  2. Vogel, John S.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422

W

  1. Wallace, Michael A.

    1. You have access
      EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422
  2. Wanders, Ronald J. A.

    1. You have access
      VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304
  3. Wang, Bonnie

    1. You have access
      THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
      Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
  4. Wang, Regina W.

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
  5. Weiss, H. Markus

    1. You have access
      HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497
  6. Williams, J. Andrew

    1. You have access
      DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794

X

  1. Xiang, Hong

    1. You have access
      TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING NUDE MICE
      Hong Xiang, Cindy B. Nguyen, Sean K. Kelley, Noel Dybdal and Enrique Escandón
      Drug Metabolism and Disposition November 2004, 32 (11) 1230-1238; DOI: https://doi.org/10.1124/dmd.104.000323

Y

  1. Yan, Bingfang

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  2. Yang, Dongfang

    1. You have access
      DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786
  3. Yeo, K. Rowland

    1. You have access
      MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180

Z

  1. Zamora, Ismael

    1. You have access
      STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
      Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen M. Masimirembwa and Ismael Zamora
      Drug Metabolism and Disposition November 2004, 32 (11) 1218-1229; DOI: https://doi.org/10.1124/dmd.32.11.1218
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 32 (11)
Drug Metabolism and Disposition
Vol. 32, Issue 11
1 Nov 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics